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Abstract
 
Increasing evidence indicates that dendritic cells (DCs) are the antigen-presenting cells of the
 
primary immune response.
 
 
 
However, several reports suggest that B lymphocytes could be re-
quired for optimal T cell sensitization. We compared the immune responses of wild-type and B
 
cell-deficient (
 
m
 
MT) mice, induced by antigen emulsified in adjuvant or pulsed on splenic
dendritic cells. Our data show that lymph node cells from both control and 
 
m
 
MT animals were
primed, but each released distinct cytokine profiles. Lymph node T cells from control animals
secreted interferon (IFN)-
 
g
 
, interleukin (IL)-2, and IL-4, whereas those from 
 
m
 
MT mice pro-
duced IFN-
 
g
 
 and IL-2 but no IL-4. To test whether B cells may influence the T helper cell
type 1 (Th1)/Th2 balance by affecting the function of DCs, we immunized mice by transfer-
ring antigen-pulsed DCs from wild-type or mutant mice. Injection of control DCs induced the
secretion of IL-4, IFN-
 
g
 
, and IL-2, whereas administration of DCs from 
 
m
 
MT animals failed
to sensitize cells to produce IL-4. Analysis of IL-12 production revealed that DCs from 
 
m
 
MT
mice produce higher levels of IL-12p70 than do DCs from wild-type animals. These data sug-
gest that B lymphocytes regulate the capacity of DCs to promote IL-4 secretion, possibly by
downregulating their secretion of IL-12, thereby favoring the induction of a nonpolarized im-
mune response.
Key words: T helper cell type 1/type 2 balance • primary response • interleukin 4 • 
interleukin 10 • dendritic–B cell interaction
 
Introduction
 
The specificity, amplitude, and character of an immune re-
sponse are determined early on, at the stage of antigen pre-
sentation. Among the population of APCs, which includes
 
dendritic cells (DCs),
 
1
 
 B lymphocytes, and macrophages,
DCs have the unique capacity to sensitize naive T cells (for
review see reference 1) and are considered the sentinels that
switch on the immune system at the appropriate “danger”
signal. This property correlates with several unique fea-
tures, including high expression of MHC and costimula-
tory molecules, motility, efficient antigen capture and pro-
cessing, specialization of function over time, production of
T cell–activating cytokines, etc.
Injection of splenic DCs, pulsed extracorporeally with
antigen, induces the development of Th cells secreting a
large array of cytokines (IL-2, IFN-
 
g
 
, IL-4, IL-5, and IL-
10) in syngeneic animals. The capacity of DCs to direct the
development of selected Th populations has been shown to
be modulated by pathogens, cytokines, and other environ-
mental factors (2). In particular, we have shown that DCs
may induce the development of Th0 (or Th1 and Th2)
lymphocytes in a neutral environment, and the differentia-
tion of a polarized Th1 or Th2 population in the presence
of IL-12 or IL-10, respectively (3).
The role of B cells (which represent the most abundant
APC population) in T cell priming is still controversial.
Several studies have revealed a critical role for B cells in the
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 DC, dendritic cell; 
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MT, B cell–deficient. 
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T cell response in vivo (4–6). These results were challenged
by reports showing that the absence of B cells had little im-
pact on T cell responsiveness (7, 8). More recently, a few
studies have suggested that B cells are not required for T
cell sensitization but play an essential role in the induction
of IL-4 gene expression by T lymphocytes (9, 10).
In this study, we compared the development of antigen-
specific responses in B cell–deficient and wild-type mice.
Our data demonstrate that the development of IL-4–secret-
ing cells was impaired in the absence of B lymphocytes.
We further determined that DCs from B cell–deficient
mice had a reduced capacity to induce IL-4 production.
These observations suggest that B lymphocytes regulate the
Th1/Th2 polarized effector function of DCs in vivo.
 
Materials and Methods
 
Mice.
 
C57BL/10, C57BL/6, C57BL/6, and 10-Igh-6
 
tm1Cgn
 
(B cell–deficient, or 
 
m
 
MT, mice; reference 11) and C57BL/10-
Il10
 
tm1Cgn
 
 (IL-10–deficient; reference 12) mice were purchased
from The Jackson Laboratory. Some C57BL/6 mice were pur-
chased from Charles River Laboratories. All animals were main-
tained in our pathogen-free facility and used at 8–12 wk of age.
 
Culture Media.
 
The medium used for the isolation of DCs was
RPMI 1640 (Seromed; Biochem KG) supplemented with 2% HY
(Ultroser HY; Life Technologies) and additives. Lymph node cells
from mice injected with KLH in CFA or KLH-pulsed DCs were
cultured in Click’s medium (Irvin Scientific) supplemented with 0.5%
heat-inactivated FCS or mouse serum, respectively, and additives.
 
Antigen, Antibodies, and Cytokines.
 
The antigen used was
KLH from Calbiochem-Novabiochem. The following antibodies
were used in this study: anti-Thy 1.2 (HO134; American Type
Culture Collection, or ATCC), anti-I-A
 
b
 
 (25.9.17; ATCC),
anti–heat stable antigen (anti-HSA; ATCC), anti-Fc
 
g
 
R (2.4G2;
ATCC), anti-CD45R/B220 (RA3-6B2; PharMingen), rat anti–
mouse IgG2a (LO-MG2a-7; provided by H. Bazin, Université
Catholique de Louvain, Brussels, Belgium), 5D9 and 5C3 (rat
anti–IL-12 p40; provided by Dr. Presky, Hoffmann-LaRoche,
Nutley, NJ), and C17.8 (rat IgG2a anti–IL-12 p40). Murine re-
combinant IL-10 was purchased from PeproTech.
 
Purification of DCs.
 
DCs were purified from spleens as shown
previously (13), except that spleen cells were digested with colla-
genase, further dissociated in Ca
 
2
 
1
 
-free media in the presence of
EDTA, separated into low and high density fractions on a Nyco-
denz gradient, and cultured overnight with KLH (50 
 
m
 
g/ml). In
some experiments, DCs were incubated with 20 ng/ml murine
recombinant IL-10. After overnight culture, nonadherent cells
contained at least 90% of DCs, as assessed by morphology and
specific staining, using anti-CD11c mAb, N418 (14).
 
Injections.
 
DCs were purified from either untreated animals
or mice treated with FLT3L, as indicated in the legend to Figs. 2
and 3, and to Fig. 4 D. For FLT3L treatment, mice were injected
intraperitoneally with 10 
 
m
 
g of recombinant human FLT3L daily
for 9 d. The immunization protocols were as follows: KLH (100
 
m
 
g) in CFA or KLH-pulsed DCs (administered at a dose of 3 
 
3
 
10
 
5
 
 cells) were injected into the fore and hind footpads, according
to a protocol described by Inaba et al. (15). Draining popliteal and
axillary lymph nodes were harvested 5 or 6 d after injection, as
indicated in the legend to Figs. 1, 2, 4 D, and 5.
 
FACS™ Analysis.
 
Low density spleen cells (see above) were
double stained for CD11c expression using FITC-conjugated
 
N418 and for CD8
 
a
 
 expression using PE-conjugated anti-CD8
 
a
 
mAb (PharMingen). The cells were gated based on characteristic
forward and light scatter, and analyzed on a FACSort™ (Becton
Dickinson).
 
In Vitro Assays.
 
Unseparated lymph node cells (4 
 
3
 
 10
 
5
 
) were
cultured in graded doses of KLH. In some experiments, 2 
 
3
 
 10
 
5
 
purified T cells were incubated with graded doses of irradiated,
KLH-pulsed spleen cells depleted of T lymphocytes by treatment
with anti-Thy1.2 mAb and rabbit complement (BioMérieux s.a.).
Lymph node T cells were purified by negative selection: in brief,
pooled lymph node cells were incubated with anti–I-A
 
b
 
 (25-9-
17), anti-HSA, anti-Fc
 
g
 
R, anti-CD45R/B220, and rat anti–
mouse IgG2a mAbs at 4
 
8
 
C, followed by goat anti–rat IgG-coated
beads (BioMag; PerSeptive Biosystems) and further passed over a
magnet. Reanalysis of the selected population confirmed purity of
 
.
 
95%. Proliferation was measured as thymidine incorporation
during the last 16 h of a 3-d culture. Culture supernatants were as-
sayed for IL-2 after 24 h of incubation, for IL-4 after 48 h, for
IFN-
 
g
 
 after 72 h, and IL-5 and IL-10 after 96 h. IL-2 and IFN-
 
g
 
were measured as previously described (3). IL-4, IL-5, and IL-10
were quantified by two-site ELISA from PharMingen.
 
PCR Analysis of IL-10 Gene Expression.
 
RNA was extracted
from splenocytes from untreated C57BL/6, 
 
m
 
MT, or anti-CD3–
injected C57BL/6 mice, from B cell-enriched CD19
 
1
 
 C57BL/6
spleen cells, and from T cell hybridoma 3B14.15 using the
TriPure reagents (Boehringer). The CD19
 
1
 
 cells were enriched
from spleen cells by incubation with anti-CD19–coupled micro-
beads and positive selection over a MACS column (Miltenyi Bio-
tec). After preparation of cDNA, PCR was performed essentially
as previously described (16). Reactions were incubated in a Per-
kinElmer/Cetus DNA thermal cycler for 30 cycles for IL-10 gene
expression and 24 cycles for housekeeping HPRT gene expres-
sion (denaturation: 30 s, 94
 
8
 
C; annealing: 1 min, 57
 
8
 
C; extension:
1 min, 72
 
8
 
C). Primers used were as follows: IL-10 sense primers
5
 
9
 
-TCAAACAAAGGACCAGCTGGACAACATACTGC-3
 
9
 
 and
antisense 5
 
9
 
-CTGTCTAGGTCCTGGAGTCCAGCAGACT-
CAA-3
 
9
 
 (amplified fragment of 421 bp). HPRT sense primers:
5
 
9
 
-GTTGGTATACAGGCCAGACTTTGTTG-3
 
9
 
 and anti-
sense 5
 
9
 
-GAATTTCAACTTGCGCTCATCTTAGGC-3
 
9
 
 (am-
plified fragment of 163 bp).
 
Production of IL-12 by DCs.
 
Purified DCs (see above) were
cultured in medium alone (RPMI 1640 supplemented with 5%
FCS) or in the presence of 3T3 fibroblasts transfected or not with
CD40L. The supernatants were assayed for IL-12 p40 after 48 h
using a two-site ELISA (3). IL-12 p70 production was monitored
on 72 h supernatants by a bioassay based on the ability of IL-12 to
induce IFN-
 
g
 
 production by spleen cells. In brief, culture super-
natants were added to 5 
 
3
 
 10
 
5
 
 spleen cells and incubated for 72 h.
IFN-
 
g
 
 content from culture supernatants was assayed using two-
site ELISA, as described above. A linear standard curve was gen-
erated by incubating spleen cells with serial dilutions of recom-
binant murine IL-12. Specificity of bioassay was confirmed by
inhibiting IFN-
 
g
 
 production with neutralizing anti–IL-12 p40
mAb (C17.8, rat IgG2a).
 
Results
 
Responses of T Cells in 
 
m
 
MT and B6 Mice to KLH.
 
We
first compared the immune response of mice that are ge-
netically deficient for B lymphocytes (
 
m
 
MT mice) and their
control littermates. 
 
m
 
MT and wild-type animals were in-
jected in the footpads with KLH emulsified in CFA and the 
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draining lymph nodes were harvested 5 d later. The data in
Fig. 1 indicate that KLH-specific T cells were primed in
both groups of mice, as assessed by KLH-dependent prolif-
eration in culture. Of note, the analysis of the cytokines re-
leased by lymph node cells revealed a differential T helper
development in 
 
m
 
MT versus control mice. T lymphocytes
from wild-type mice secreted IFN-
 
g
 
 and IL-4 when re-
challenged with KLH in vitro
 
,
 
 whereas T cells from 
 
m
 
MT
mice produced higher levels of IFN-
 
g
 
 but no detectable
 
IL-4 in the same conditions. These observations indicate
that B lymphocytes are dispensable for T cell priming but
are required for the development of IL-4–secreting cells.
 
Impaired Ability of DCs from 
 
m
 
MT Mice to Promote IL-4
Secretion.
 
There is increasing evidence that the cell that
presents the antigen to T cell may influence the Th1/Th2
balance in vivo. In particular, injection of splenic DCs has
been shown to induce the activation of T cells that secrete
a large array of cytokines (3, 17). Because DCs are the
Figure 1. Responses of T cells in mMT and C57BL/6
mice to KLH. Wild-type (black symbols) or mMT (white
symbols) mice were injected into the footpads with 100 mg
KLH emulsified in CFA. Lymph nodes were harvested 5 d
later and purified T cells (2 3 105/well) were incubated
with graded numbers of irradiated, T-depleted spleen cells
from C57BL/6 mice that had been pulsed with KLH (100
mg/ml). Proliferation and cytokine production were mea-
sured as indicated in Materials and Methods. Limits of de-
tection: for IL-2, 0.16 U/ml; for IL-4, 31.25 pg/ml; for
IFN-g, 0.03 ng/ml. The data are representative of four in-
dependent experiments using pooled T cells from five
C57BL/6 or mMT mice and shown as the mean of dupli-
cate cultures 6 SD.
Figure 2. DCs from mMT mice do not prime for
IL-4. C57BL/10J were injected with KLH-pulsed DCs
from FLT3L-treated C57BL/10J (black symbols) or
mMT (white symbols) mice into the hind and fore
footpads. Lymph node cells were harvested 6 d later
and cultured with KLH (5 mg/ml). Proliferative re-
sponses and cytokine secretion were measured as indi-
cated in Materials and Methods. Each symbol repre-
sents the response of a single mouse and vertical bars
are the mean results of five mice of each type (6 SD).
Five independent experiments were performed with
similar results using DCs from untreated or FLT3L-
treated mice. Limits of detection: for IL-2, 0.16 U/ml;
IL-4 and IL-5, 62.5 pg/ml; IFN-g, 0.3 ng/ml; IL-10, 1
ng/ml. The groups indicated by single and double as-
terisks are significantly different from control (Student’s
t test, P , 0.05 and 0.01, respectively; n 5 5). 
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APCs of the primary immune response, we analyzed the
adjuvant function of DCs purified from control and 
 
m
 
MT
mice. DCs were purified from spleens and pulsed with
KLH during overnight culture, as previously described
(17). Of note, expression of B7-1, B7-2, and CD40 mole-
cules was similar on DCs from both strains of mice,
whereas MHC class II was expressed at slightly higher lev-
els on DCs from 
 
m
 
MT animals (data not shown). 3
 
 
 
3
 
 
 
10
 
5
 
DCs were injected into the footpads of wild-type mice,
and the lymph nodes were harvested 6 d later. The data in
Fig. 2 show that DCs from wild-type and 
 
m
 
MT mice dif-
ferentially regulated the development of Th cells. Injection
of DCs from 
 
mMT mice induced the differentiation of cells
secreting IL-2, IFN-g, IL-5, and IL-10, but no detectable
IL-4, whereas DCs from control mice prime for IL-4 pro-
duction in addition to other cytokines.
DCs from mMT Mice Produce Higher Levels of Bioactive IL-
12. Because IL-12 appears to be the dominant cytokine
favoring the differentiation of Th1 cells over Th2 cells, we
measured the production of IL-12 by DCs upon in vitro
stimulation. The data in Fig. 3 show that DCs from mMT
mice produced higher levels of IL-12 homodimer (p40)
and heterodimer (p70) than did DCs from wild-type mice.
This observation suggests that the lack of IL-4 priming
upon immunization with DCs from B cell–deprived mice
may result from increased production of IL-12 by trans-
ferred DCs. By contrast, DCs from wild-type mice release
lower amounts of IL-12 and have the capacity to promote
IFN-g and IL-4 production upon adoptive transfer. We
next compared the number of CD8a1 and CD8a2 DCs in
wild-type and mMT mice, since only the subset of DCs ex-
pressing CD8a has been shown to produce IL-12 (18, 19).
The data in Table I show that the proportion of DC subsets
is similar in both strains of mice.
IL-10 Message Is Downregulated in Spleen Cells from mMT
Mice. IL-10 has been shown to downregulate IL-12 pro-
duction, thereby favoring the onset of a Th2-type re-
sponse. We measured the level of IL-10 mRNA in unstim-
ulated spleen cells from both strains of mice. The data in
Fig. 4 A indicate that IL-10 message was decreased in mMT
mice, as compared with control animals, suggesting that B
cells promote IL-10 secretion. Of note, splenic CD191
lymphocytes (containing at least 98% B cells, as assessed by
expression of IgM: Fig. 4 C) constitutively express mRNA
specific for IL-10 (Fig. 4 B). To better define the role of
IL-10 in the regulation of IL-12 secretion by DCs, we
transferred DCs from IL-10–deficient mice into wild-type
recipients. As shown in Fig. 4 D, DCs from IL-10 knock-
out animals induced an immune response characterized by
the development of T cells secreting very low amounts of
IL-4 and IL-10.
Role of the Microenvironment. To test whether the mi-
croenvironment in which priming of T cells occurs may
influence the character of the immune response, KLH-
pulsed DCs from wild-type animals were transferred into
control and B cell–deprived recipient mice. As shown in
Fig. 5, immunization of mMT mice resulted in sensitization
of cells producing high levels of IFN-g and low levels of
IL-4, whereas priming of wild-type mice induced lower
IFN-g and higher IL-4 production. Evidence that T cells
from mMT mice have the capacity to produce IL-4 is pro-
vided by the observation that injection of Th2-prone, IL-
10–treated DCs into mMT mice results in the development
of IL-4–secreting cells (Table II).
Figure 3. Production of IL-12 by DCs. DCs purified from untreated
WT (DCB1/1) or mMT (DCB2/2) mice were cultured with medium
alone (None) or with fibroblasts transfected (CD40L-3T3) or not (3T3)
with CD40L. 48-h and 72-h supernatants were tested for IL-12 p40 and
p70 content, respectively. Limits of detection: for p40, 0.3 pg/ml; p70,
0.13 pg/ml. Data shown are the mean 6 SD of duplicate cultures. Three
independent experiments were performed with similar results, using DCs
purified from untreated or FLT3L-treated mice.
Table I. Analysis of DC Subsets
Wild-type mice mMT mice
CD8a2 CD8a1 CD8a2 CD8a1
1 64.8 35.2 67.8 32.2
2 60.0 40.0 75.0 25.0
3 80.6 19.4 78.1 21.9
4 83.0 17.0 70.7 29.3
Low density spleen cells from FLT3L-injected (1 and 2) or untreated (3
and 4) mice were double stained for CD8a expression using PE-
conjugated anti-CD8a mAb and for CD11c expression using FITC-
conjugated N418. The data represent the percentage of CD8a2 and
CD8a1 cells among DCs (gated for N418 expression).479 Moulin et al.
Discussion
The results reported here show that B lymphocytes have
a profound regulatory effect on the antigen-presenting
function of DCs in vivo. Indeed, DCs from B cell–deprived
animals have an impaired capacity to induce antigen-spe-
cific differentiation of IL-4–secreting T cells when trans-
ferred in control animals. The diminished IL-4–promoting
capacity of DCs correlates with an enhanced production of
IL-12. These observations suggest that B lymphocytes in-
teract with DCs and lower the level of IL-12 released by
DCs, thereby leading to priming of both Th1 and Th2
lymphocytes. Of note, it has been shown that interactions
between DCs and B cells may occur regularly during B cell
recirculation. The interaction is thought to be confined to
small B cells, is totally T cell and antigen independent, and
is not MHC restricted (20). Furthermore, cooperation be-
tween DCs and B lymphocytes has been demonstrated by
Dubois et al. (21), who showed that in vitro–generated
DCs promote the proliferation of naive and CD40-acti-
vated B cells and produce factors that induce differentiation
of activated B cells into plasma cells. Our observations
show that a bidirectional regulation occurs upon DC–B
cell interaction.
Figure 4. Role of IL-10. (A) RT-PCR
analysis of IL-10 expression was performed
in spleen cells from untreated wild-type
(lanes 1 and 2) and mMT (lanes 3 and 4)
mice, using IL-10 and HPRT primers.
Anti-CD3–injected mice were used as posi-
tive control (lane 5). Left and right sides
represent the amplification by PCR of 3l
and 1l cDNA, respectively. Similar data
were obtained in three independent ex-
periments. (B) RT-PCR analysis of IL-10
expression was performed in unseparated
spleen cells (lane 1) and splenic CD191 cell
population (lane 2), which contains 98% B
lymphocytes as assessed by FACS™ analysis
for IgM expression (C). The T cell hybrid-
oma 3B4.15 was used as negative control
(panel B, lane 3). (D) DCs were purified
from C57BL/10 (black symbols) or IL-10
knockout (white symbols) mice that were
treated for 9 d consecutively with FLT3L.
KLH-pulsed DCs were injected into the
hind and fore footpads of wild-type recipi-
ent animals. Lymph nodes were harvested
6 d later and cultured with KLH (5 mg/ml).
The supernatants were collected and cyto-
kine activities were determined by ELISA.
Detection limits: for IFN-g, 0.3 ng/ml;
IL-4, 31.3 pg/ml; IL-5, 31.3 U/ml; IL-10,
1 ng/ml. Each symbol represents produc-
tion of cytokine of individual animals, and
vertical bars are the mean results of five
mice. Two independent experiments were
performed with similar results. The groups
indicated by the double asterisks are signifi-
cantly different from control (Student’s t
test, P , 0.01, n 5 5).480 Regulation of Dendritic Cells by B Lymphocytes
Although we do not have direct evidence, several fea-
tures suggest that IL-10 may be involved in this immuno-
regulatory process: splenocytes from mMT mice express re-
duced levels of IL-10 mRNA than wild-type animals; DCs
from IL-10 knockout mice display properties similar to
DCs from mMT mice, i.e., they have lost the capacity to
induce the development of IL-4–secreting cells; treatment
of DCs from mMT mice with IL-10 restored the genera-
tion of IL-4–producing cells in vivo; and numerous reports
have shown that IL-10 inhibits the production of IL-12
heterodimer by DCs in vitro and in vivo (3, 10). Collec-
tively, these observations suggest that the level of IL-12 re-
leased by DCs is regulated by B lymphocytes, presumably
via the production of IL-10. Our data show that B lym-
phocytes may produce IL-10 constitutively. B cell–depleted
spleen cells also express mRNA for IL-10 (data not
shown), suggesting that other cell populations may indi-
rectly control the level of IL-12.
There is evidence that the level of IL-12 released by
transferred DCs determines the Th1/Th2 balance in vivo.
DCs from wild-type animals produce intermediate levels of
IL-12 and induce the development of T cells producing IL-2,
IFN-g, IL-4, IL-5, and IL-10 (this paper and reference
17). DCs, treated with IL-10 in culture, secrete decreased
amounts of IL-12 and direct the differentiation of Th2-
type cells (3), similar to the response induced by DCs from
IL-12–deficient mice (3). Conversely, DCs from IL-10– or
B cell–deficient mice release increased levels of IL-12 and
do not promote IL-4 secretion (this paper). Coadministra-
tion of IL-12 with the wild-type DCs results in sensitiza-
tion of Th1-type cells only (17). Therefore, the develop-
ment of IL-4–secreting T lymphocytes appears as a default
when T cells are sensitized in the presence of low levels of
IL-12. Whether IL-12 directly or indirectly inhibits the de-
velopment of Th2-type cells is still a matter of speculation.
Our observations indicate that DCs from B cell–deprived
mice have lost the ability to prime for IL-4 production but
have retained the capacity to induce the development of
cells producing diminished but still significant amounts of
IL-5 and IL-10. The lack of association of expression
among IL-4, IL-5, and IL-10 has been recently reported by
Kelso et al. (22), who analyzed the single-cell expression
patterns in type 1– or type 2–polarized responses.
Our data also show that DCs from wild-type mice in-
jected in a mMT host induce the development of T cells
secreting IL-2 and IFN-g, but not IL-4. Whether B lym-
phocytes limit IL-12 synthesis by transferred DC homing
in the T cell area of lymph nodes remains to be deter-
mined. Additional studies, including injection of labeled
DCs in the footpad and staining of lymph node sections for
IL-12 p70, would help clarify this point. Interestingly,
Figure 5. B cells from recipient animals are required for
IL-4 priming. KLH-pulsed DCs from untreated C57BL/
10 mice were injected into the hind and fore footpads of
wild-type (black symbols) or mMT (white symbols) recipi-
ents. Lymph nodes were harvested 6 d later and purified T
cells were cultured with various numbers of g-irradiated, T
cell–depleted spleen cells from C57BL/10 mice, which
have been pulsed with KLH. Proliferation and lymphokine
production were measured as indicated in Materials and
Methods. Detection limits: for IL-2, 0.16 U/ml; IFN-g,
0.3 ng/ml; IL-4, 16 pg/ml. The results represent the mean
of duplicate cultures (6 SD). Similar data were obtained in
three independent experiments.
Table II. IL-10–treated DCs Induce T Cells from mMT Mice to 
Secrete IL-4
Recipient: Control mice mMT mice
Injected 
with:
Untreated
DCs
Untreated
DCs
IL-10–treated
DCs
Exp. 1
1 305.4 6 3.1 80.6 6 3.1 305.9 6 52.4
2 187.7 6 0.8 Not detectable 242.8 6 17.8
Exp. 2
1 593.3 6 73.4 63.7 6 35.6 318.5 6 31.1
2 204.4 6 8.3 45.3 6 0.5 610.0 6 52.3
Secretion of IL-4 (in pg/ml) by lymph node T cells. Untreated or IL-
10–treated DCs from wild-type mice were pulsed in vitro with KLH (50
mg/ml) and injected into the fore and hind footpads of control or mMT
mice. 6 d later, lymph node cells were harvested and cultured with 5
mg/ml KLH and the Il-4 content was assessed by ELISA. Exp. indicates
the experiment number; the indented numbers refer to individual mice.
Limit for detection is 31.25 pg/ml.481 Moulin et al.
Wykes et al. (23) have shown that DCs can retain unpro-
cessed antigen and directly interact with B lymphocytes to
initiate antibody synthesis. Thus, B cells recognizing the
antigen expressed by DCs form short-lived clusters and
could give regulatory signals to the transferred DCs. Alter-
natively, direct B to T cell signaling may promote IL-4
synthesis in this experimental model. It is noteworthy that
T cells from mMT mice have the capacity to produce IL-4,
as T cells from mMT mice produced high amounts of IL-4
in response to Schistosoma mansoni eggs (8) or Onchocerca vol-
vulus (24). The capacity of T cells from mMT mice to se-
crete IL-4 is further illustrated by the observation that in-
jection of DCs that have been treated with IL-10 to
enhance their capacity to promote Th2 development (3)
induces the production of significant levels of IL-4 in mMT
recipient mice (Table II).
We and others have reported that subclasses of DCs di-
rected the development of distinct T helper cells in vivo
(18, 19). Thus, CD8a1 and CD8a2 DCs, purified from
spleens, have the potential to differentially regulate the
Th1/Th2 balance: CD8a2 DCs induced the activation of
cells secreting high levels of IL-4, IL-5, and IL-10, and low
levels of IL-2 and IFN-g, whereas CD8a1 DCs sensitize
cells producing IL-2 and IFN-g, but little IL-4, IL-5, or
IL-10. We therefore compared the numbers of DCs of ei-
ther subset in mMT and wild-type mice. Little difference
was found between these strains, suggesting that B lympho-
cytes did not alter the distribution of DC subsets (Table I).
Of note, the number of DCs was consistently reduced (by
approximately twofold) in B cell–deprived mice as com-
pared with wild-type animals, an observation that may re-
sult from a lack of survival or maturation signals and/or
chemoattractants factors such as B cell–derived chemokines
macrophage inflammatory protein (MIP)-1a and MIP-1b
(25).Our results are consistent with the observations of
Stockinger et al. (10) that the B cell is the crucial APC for
the development of Th2 responses. Stockinger et al. also
recently have identified a feedback loop triggered by IL-12
that promotes Th2 differentiation (26). Thus, delivery of
IL-12 by DCs during B cell activation induces the secretion
of IL-6 and IL-10 by activated B cells. IL-6 and IL-10 con-
fer the capacity to induce IL-4 expression in T cells to
these B lymphocytes. These data were interpreted to indi-
cate that DCs, through IL-12 secretion, enhance the ability
of B cells to influence T cell differentiation toward Th2.
Our data further extend these observations by showing that
DCs themselves, after interaction with B cells, show higher
IL-4–inducing activity.
Interestingly, our results may shed new light on the
enigmatic observation that mMT mice showed enhanced
CTL activity to tumor cells in comparison to their control
littermates (27). Qin et al. reported that the presence of B
cells in the priming phase resulted in disabled help for
CTL-mediated tumor immunity, and interpreted these data
by a competition between B cells and other APCs for anti-
gen. Our data suggest that the absence of B cells may en-
hance the generation of tumor immunity by promoting a
polarized Th1 response.
In conclusion, our observations suggest that at the steady
state level, IL-10 released by B lymphocytes may control the
level of IL-12 released by DCs, which upon encounter with
an antigen would induce an unpolarized immune response.
In addition, there is evidence that presentation of antigen by
B lymphocytes may preferentially direct the development of
Th2-type cells (28, 29). Therefore, B cells may directly
(upon interaction with T cells) or indirectly (by controlling
IL-12 production via DCs) favor the development of Th2-
type cells that provide helper activity for antibody synthesis,
thereby promoting their own effector function.
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